Micronized Palmitoylethanolamide Reduces the Symptoms of Neuropathic Pain in Diabetic Patients
Figure 3
Effects of micronized PEA on single subcategories of neuropathic pain symptoms measured by Neuropathic Pain Symptoms Inventory (NPSI). ANOVA confirmed the significant improvement, compared to baseline (), of the more important characteristics of neuropathic pain: spontaneous superficial pain burning, deep spontaneous pressing pain, paroxysmal pain, and evoked pain (paresthesia/dysesthesia) evaluated by NPSI.
